Search research articles
Contact Us
Filters
Showing results (1-10 of 233) with videos related to
Page
of 24
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
November 17, 2020
Epstein-Barr Virus-Associated Post-transplant Lymphoproliferative Disease
Richard F Ambinder
The Journal of Clinical Investigation
|
May 8, 2018
A viral protein kinase drug target for tumors?
Richard F Ambinder
Blood
|
September 24, 2016
EBV, an inhibited receptor kinase, and lymphoma
Richard F Ambinder
Hematology. American Society of Hematology. Education Program
|
November 21, 2007
Epstein-barr virus and hodgkin lymphoma
Richard F Ambinder
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2009
Evaluation of T- and NK-cell-targeted therapies: is there a role for rituximab prophylaxis?
Richard F Ambinder
The New England Journal of Medicine
|
August 10, 2017
Plasma Epstein-Barr Virus DNA for Screening
Richard F Ambinder
Current Oncology Reports
|
August 5, 2003
Posttransplant lymphoproliferative disease: pathogenesis, monitoring, and therapy
Richard F Ambinder
Hematology/Oncology Clinics of North America
|
July 11, 2003
Viruses as potential targets for therapy in HIV-associated malignancies
Richard F Ambinder
Reviews in Clinical and Experimental Hematology
|
May 8, 2004
Epstein-Barr virus-associated lymphoproliferative disorders
Richard F Ambinder
CA: a Cancer Journal for Clinicians
|
December 2, 2017
Hodgkin lymphoma: A review and update on recent progress
Satish Shanbhag, Richard F Ambinder
Page
of 24
Search research articles
Search
Showing results (1-10 of 233) with videos related to
Sort By:
Page
of 24
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
November 17, 2020
Epstein-Barr Virus-Associated Post-transplant Lymphoproliferative Disease
Richard F Ambinder
The Journal of Clinical Investigation
|
May 8, 2018
A viral protein kinase drug target for tumors?
Richard F Ambinder
Blood
|
September 24, 2016
EBV, an inhibited receptor kinase, and lymphoma
Richard F Ambinder
Hematology. American Society of Hematology. Education Program
|
November 21, 2007
Epstein-barr virus and hodgkin lymphoma
Richard F Ambinder
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2009
Evaluation of T- and NK-cell-targeted therapies: is there a role for rituximab prophylaxis?
Richard F Ambinder
The New England Journal of Medicine
|
August 10, 2017
Plasma Epstein-Barr Virus DNA for Screening
Richard F Ambinder
Current Oncology Reports
|
August 5, 2003
Posttransplant lymphoproliferative disease: pathogenesis, monitoring, and therapy
Richard F Ambinder
Hematology/Oncology Clinics of North America
|
July 11, 2003
Viruses as potential targets for therapy in HIV-associated malignancies
Richard F Ambinder
Reviews in Clinical and Experimental Hematology
|
May 8, 2004
Epstein-Barr virus-associated lymphoproliferative disorders
Richard F Ambinder
CA: a Cancer Journal for Clinicians
|
December 2, 2017
Hodgkin lymphoma: A review and update on recent progress
Satish Shanbhag, Richard F Ambinder
Page
of 24